Forte Biosciences CEO Marty Duvall's 2020 pay falls 34% to $1.2M

Forte Biosciences reports 2020 executive compensation

By ExecPay News

Published: April 30, 2021

Forte Biosciences reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, four executives at Forte Biosciences received on average a compensation package of $924K, a 15% decrease compared to previous year.
Average pay of disclosed executives at Forte Biosciences
Marty J. Duvall, Chief Executive Officer, received $1.2M in total, which decreased by 34% compared to 2019.
Antony Riley, Chief Financial Officer, received a compensation package of $1.1M. 65% of the compensation package, or $682K, was in option awards.
Paul A. Wagner, Chief Executive Officer, earned $777K in 2020, a 48% increase compared to previous year.
Mark Foletta, Chief Financial Officer, received $690K in 2020, which decreases by 30% compared to 2019.

Related executives

Paul Wagner

Forte Biosciences

Chief Executive Officer

Marty Duvall

Forte Biosciences

Chief Executive Officer

Antony Riley

Forte Biosciences

Chief Financial Officer

Mark Foletta

Forte Biosciences

Chief Financial Officer

You may also like

Source: SEC filing on April 30, 2021.